Pfizer
Long

Buy the Drug Dip

622
This one surprised me with a poor earnings report, but my outlook remains the same. All indicators point to a bounce.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.